Pilatus Biosciences, Inc., a clinical-stage biopharmaceutical company developing novel metabolic checkpoint immunotherapies for liver and gastrointestinal cancers, today announced the first patient ...
Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center of a much larger medical revolution.
Research Development & Programs Undergraduate Programs Transfer to STEM Student Success (TS3) Velay Summer Undergraduate Research Fellowship (VSURF) Transfer to STEM Student Success (TS3) CUNY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results